Skip to main navigation menu Skip to main content Skip to site footer

Morphological changes and inhibition of the growth of Candida albicans in the presence of solution sulfate of a zinc sulfate of zinc

Cambios morfológicos e inhibición del crecimiento de Candida albicans en presencia de una solución de sulfato de zinc




Section
Artículo Original Producto de Investigación

How to Cite
Gallón Nausa, J. (2015). Morphological changes and inhibition of the growth of Candida albicans in the presence of solution sulfate of a zinc sulfate of zinc. NOVA, 13(23). https://doi.org/10.22490/24629448.1370

Dimensions
PlumX
license

Licencia Creative Commons

NOVA by http://www.unicolmayor.edu.co/publicaciones/index.php/nova is distributed under a license creative commons non comertial-atribution-withoutderive 4.0 international.

Furthermore, the authors keep their property intellectual rights over the articles.

 

Julián Gallón Nausa

    Objective. Identify isolations of C. albicans, in children from 4 to 12 years, of a population of 189 individuals and to evaluate the above mentioned isolations opposite to three concentrations (3 %, 5 % and 7 %) of Sulfate of Zinc. Methods. There were in use the technologies of the Minimal Inhibitory Concentration (CMI) and Kirby Bauer’s technology, according to the parameters of the Clinical Laboratory Standards Institute (CLSI). Results: In CMI’s method, with the concentrations of 3 % and 5 % one found a decrease in the forming Units of Colonies (UFC) related to the time (24, 48 and 72 hours) compared with the vine-stock control. As for the concentration of 7 %, they did not present forming units of colonies in any of three observed times. With Kirby Bauer’s technology, the concentration of 3 % did not present inhibition of the growth; to the concentrations of 5 % and 7 % one presented a halo of 16 mm and 20 mm respectively. The analysis of Microscopy and Electronic Sweep (MBE), it reveals that the Sulfate of Zinc of 3 % and 5 % they present formation of biopelicula and pseudomicelio, unlike the concentration of 7 % where it was observed lisis cellular in all the fields.

    Article visits 149 | PDF visits 160


    Downloads

    Download data is not yet available.
    1. Hernándezâ€Solís SE, Ruedaâ€Gordillo F, Pereiraâ€Góngora JR, Villamilâ€Urzaiz JL.Frecuencia de portadores de C. albicans en un grupo de niños de una comunidad rural del estado de Yucatán. México. Revista Odontológica Latinoamericana. 2008; 0(1): 1â€4.
    2. Ruedaâ€Gordillo F, Hernándezâ€Solís SE. Prevalencia de Candida albicans aislada de la cavidad oral de pacientes con cáncer. México. Revista Odontológica Latinoamericana. 2008; 0(2): 38â€41.
    3. Alejandra Jaimes Aveldañez, Francisco Hernández Pérez, Erick Martínez Herrera, Alma Angélica, Rodríguez Carreón, Roberto Arenas Guzmán Portadores de Candida en la mucosa oral: tipificación de 35 cepas con Chomoagar Candida. Med Int Mex.2008; 24(4):262-6.
    4. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeats; Approved Standard, Second Edition. Clinical Laboratory Standards Institute (CLSI). 2007; 22(15).
    5. Gordon Ramage, Stephen P. Saville, Derek P. Thomas, and Jose L. Lopez-Ribot. Candida Biofilms. Eukaryotic Cell. 2005; 4: 633–638.
    6. Murciano C, Villamon E, Gozalbo D, Roig P, O'Connor JE, Gil ML. Toll-Like Receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans infections. Med Mycol. 2006 Mar; 44(2):149-57.
    7. Xin H, Cartmell J, Bailey JJ,Dziadek S, Bundle DR, Cutler JE. Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis. PLoS One. 2012; 7(4):e35106. doi: 10.1371/journal.pone.0035106. Epub 2012 Apr 26.
    8. Gladys Velazco, Reynaldo Ortiz, Leylan Arellano, Lorena Bustillos, Anajulia. Evidencia microscópica de la presencia de Candida albicans en bases protésicas retiradas de la cavidad bucal. Revista Cubana de Estomatología. 2009; 46(2).
    9. Jorge Alberto Cortés, Patricia Reyes, Carlos Gómez, Giancarlo Buitrago, Aura Lucía Leal. Fungal bloodstream infections in tertiary care hospitals in Colombia. Revista Iberoamericana de Micología. 2011; 28(2):74–78.
    10. Paula Andrea Orozco, Jorge Alberto Cortés. Colonización por levaduras en recién nacidos y personal de salud en la unidad de cuidados intensivos neonatales de un hospital universitario en Bogotá, Colombia. Parra. Rev Iberoam Micol. 2009; 26(2):108-111.
    11. Christopher F. Hoehamer, Edwin D. Cummings, George M. Hilliard, and P. David Rogers. Changes in the Proteome of Candida albicans in response to Azole, Polyene, and Echinocandin antifungal agents. Antimicrobial Agents And Chemotherapy. 2010; 54(5): 1655–1664.
    12. Laura Estela Castrillón Rivera, Alejandro Palma Ramos, María del Carmen Padilla Desgarennes. Importancia de las biopelículas en la práctica médica Dermatología. México. Rev Mex. 2010; 54(1):14-24.
    13. Govindsamy Vediyappan, Tristan Rossignol, and Christophe d’Enfert. Interaction of Candida albicans Biofilms with Antifungals: Transcriptional Response and Binding of Antifungals to Beta-Glucans. Antimicrobial agents and Chemotherapy. 2010; 54(5):2096–2111.
    14. Souza, N., Ferreira, W, Cardoso C. Dias, S. M., Pimentaimenta, F. C.1 and Toledo. Phenotypic aspects of oral strains of Candida albicans in children with down’s syndrome. Braz. J. Biol.2006; 66(3): 939-944.
    15. Mendicote Leon, F. Toxicidad y tratamientos de soporte en oncología radioterápica: toxicidad en el área de O.R.L. (Barcelona.). En: Prevención y tratamiento Oncología. 2005; 28(2):30-34.
    16. Yáñez A, Flores A, Murciano C, O'Connor JE, Gozalbo D, Gil ML.Cell Signalling through TLR2/MyD88 induces differentiation of murine bone marrow stem and progenitor cells to functional phagocytes in response to Candida albicans. Microbiol. 2010 Jan;12(1):114-28. doi: 10.1111/j.1462-5822.2009.01382.x. Epub 2009 Sep 11.
    17. Moyes DL, Shen C, Murciano C, Runglall M, Richardson JP, Arno M, Aldecoa-Otalora E, Naglik JR. 19.Protection against epithelial damage during Candida albicans infection is mediated by PI3K/Akt and mammalian target of rapamycin signaling. J Infect Dis. 2014 Jun 1;209(11):1816-26. doi: 10.1093/infdis/jit824. Epub 2013 ec.
    18. Ogata K, Matsuda K, Tsuji H, Nomoto K. Sensitive and rapid RT-qPCR quantification of pathogenicCandidaspecies in human blood. J Microbiol Methods. 2015 Jul 29. pii: S0167-7012(15)30030-0. doi: 10.1016/j.mimet.2015.07.021.
    19. Cossu A, Wang MS, Chaudhari A, Nitin N. Antifungal activity againstCandida albicansof starch Pickering emulsion with thymol or amphotericin B in suspension and calcium alginate films. Int J Pharm. 2015 Jul 28. pii: S0378-5173(15)30083-1. doi: 10.1016/j.ijpharm.2015.07.065.
    20. Luna-Tapia A, Peters BM, Eberle KE, Kerns ME, Foster TP, Marrero L, Noverr MC, Fidel PL Jr, Palmer GE. ERG2 and ERG24 are required for normal vacuolar physiology as well as Candida albicans pathogenicity in a murine model of disseminated but not vaginal candidiasis. Eukaryot Cell. 2015 Jul 31. pii: EC.00116-15.
    21. =========================================
    22. DOI: http://dx.doi.org/10.22490/24629448.1370
    Sistema OJS 3.4.0.5 - Metabiblioteca |